FundingWatcher
Home / Investors / Post IPO investors / Post IPO investors in Boston, Massachusetts

Post IPO investors in Boston, Massachusetts

Updated 16 Nov 2026

Reset
Post IPO investors in Boston, Massachusetts
One-time CSV
  • 33 firms, 31 with a website
  • 20 firm email addresses
  • 21 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-post-ipo-investors-boston-massachusetts.csv33 rows × 15 columns
InvestorTypeLocationEmailPhone
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
SV Health InvestorsPrivate equity firmBoston, United States•••@svlsa.com+1 617•••
HarbourVest PartnersPrivate equity firmBoston, United States•••@harbourvest.com+1 617•••
Advent InternationalPrivate equity firmBoston, United States•••@adventinternational.com212 81•••
Bain CapitalPrivate equity firmBoston, United States•••@baincapital.com+1 617•••
Omega FundsSecondary purchaserBoston, United States•••@omegafunds.net
Adage Capital ManagementGovernment investment officeBoston, United States•••@adagecapital.com617-86•••
Third Rock VenturesVenture capital firmBoston, United States•••@thirdrockventures.com(415) •••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-stage-post-ipo-investors-boston-massachusetts-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
SV Health InvestorsK••• B•••Managing Partnerk•••@svhealthinvestors.comIn the CSV
TA AssociatesR••• B•••Managing Director, Co-Head Financial Services, Americasr•••@ta.comIn the CSV
HarbourVest PartnersB••• K•••Managing Directorb•••@harbourvest.comIn the CSV
Advent InternationalT••• G•••Managing Partnert•••@adventinternational.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

33
Investors
20
With email
21
With phone
10
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Post IPO investors in Boston, Massachusetts

30 of 33, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Fidelity Investment bank Boston, United States Health care, Hardware Zipline International, Tenstorrent, SiMa.ai 7 586 178 285 +1-866••• In the CSV
2 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
3 SV Health Investors Private equity firm, Venture capital firm Boston, United States Health care, Biotech Alchemab Therapeutics 1 325 76 95 •••@svlsa.com +1 617••• In the CSV
4 TA Associates Private equity firm Boston, United States Hardware, Artificial intelligence Wunder Mobility, Stackline, Thinkproject 317 173 194 +1.617••• In the CSV
5 Cormorant Asset Management Hedge fund Boston, United States Health care, Biotech Triveni Bio, Third Arc Bio, BlossomHill Therapeutics 4 276 58 141 In the CSV
6 HarbourVest Partners Private equity firm Boston, United States Fintech, Hardware Varo Bank 1 273 52 147 •••@harbourvest.com +1 617••• In the CSV
7 Advent International Private equity firm Boston, United States Fintech, Hardware Coralogix, KreditBee 2 234 97 89 •••@adventinternational.com 212 81••• In the CSV
8 Bain Capital Private equity firm, Venture capital firm Boston, United States Fintech, Hardware Mintlify 1 198 89 89 •••@baincapital.com +1 617••• In the CSV
9 Omega Funds Secondary purchaser, Venture capital firm Boston, United States Biotech, Health care FoRx Therapeutics 1 161 37 75 •••@omegafunds.net In the CSV
10 Adage Capital Management Government investment office Boston, United States Artificial intelligence, Health care Welldoc 161 13 119 •••@adagecapital.com 617-86••• In the CSV
11 Third Rock Ventures Venture capital firm Boston, United States Biotech, Health care Terremoto Biosciences 1 154 69 44 •••@thirdrockventures.com (415) ••• In the CSV
12 HLM Venture Partners Venture capital firm Boston, United States Health care, Hardware ArroHealth, PatientPop, ClearDATA 138 41 51 •••@hlmvp.com 617-26••• In the CSV
13 Trustbridge Partners Private equity firm Boston, United States Education, Commerce Hope Medicine, Zilliz, huoban.com 122 44 21 •••@trustbridgepartners.com In the CSV
14 RockPort Capital Venture capital firm Boston, United States Hardware, Biotech NewLeaf Symbiotics, EcoFactor, Gazelle 108 25 26 415-78••• In the CSV
15 Atreides Management Hedge fund, Venture capital firm Boston, United States Hardware, Cybersecurity DustPhotonics, Chain Reaction 89 15 9 •••@atreidesmgmt.com 617-42••• In the CSV
16 Eventide Private equity firm, Venture capital firm Boston, United States 64 14 36 •••@eventidefunds.com +1-877••• In the CSV
17 JDRF T1D Fund Venture capital firm Boston, United States Biotech, Health care i2o Therapeutics 54 13 14 •••@jdrf.org 212-68••• In the CSV
18 K2 HealthVentures Private equity firm, Venture capital firm Boston, United States Biotech, Health care Click Therapeutics 1 51 28 24 •••@k2hv.com In the CSV
19 Material Impact Venture capital firm Boston, United States Biotech, Hardware Actnano, Tierra Biosciences, Talus Renewables 45 22 3 In the CSV
20 PAR Capital Management Venture capital firm Boston, United States Software Journera, Routehappy 39 9 11 •••@parcapital.com (617) ••• In the CSV
21 The Baupost Group Hedge fund Boston, United States Commerce Just Eat Take​away.com 38 13 20 •••@baupost.com 617-21••• In the CSV
22 Monashee Investment Management Hedge fund Boston, United States 30 1 18 •••@monasheecap.com In the CSV
23 Wavecrest Growth Partners Private equity firm Boston, United States Commerce, Artificial intelligence HICX, Dark Pools, MikMak 28 21 6 •••@wavecrestgrowth.com (857) ••• In the CSV
24 Columbia Threadneedle Investments Corporate venture arm Boston, United States 24 4 19 +1 800••• In the CSV
25 Spring Lane Capital Private equity firm Boston, United States 16 16 3 •••@springlanecapital.com (514)7••• In the CSV
26 AMR Action Fund Venture capital firm Boston, United States Biotech, Health care Elion Therapeutics 15 12 4 In the CSV
27 SVB Securities Investment bank Boston, United States 4 1 2 +1 617••• In the CSV
28 Aghadiuno John Angel investor Boston, United States Commerce MassMarketplace, Woofpage 4 0 0 In the CSV
29 ShawSpring Partners Hedge fund, Private equity firm Boston, United States 2 1 0 •••@shawspring.com In the CSV
30 Acquis Capital Family office, Venture capital firm Boston, United States 0 0 0 (617)3••• In the CSV

Table 1. Post IPO investors in Boston, Massachusetts: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 33.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 RA Capital Management Boston, United States 9 47 Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics
2 Fidelity Boston, United States 7 40 Zipline International, Tenstorrent, SiMa.ai
3 Cormorant Asset Management Boston, United States 4 13 Triveni Bio, Third Arc Bio, BlossomHill Therapeutics
4 Advent International Boston, United States 2 17 Coralogix, KreditBee
5 SV Health Investors Boston, United States 1 9 Alchemab Therapeutics
6 Third Rock Ventures Boston, United States 1 5 Terremoto Biosciences
7 Bain Capital Boston, United States 1 27 Mintlify
8 K2 HealthVentures Boston, United States 1 1 Click Therapeutics
9 HarbourVest Partners Boston, United States 1 19 Varo Bank
10 Omega Funds Boston, United States 1 11 FoRx Therapeutics

Table 2. Post IPO investors in Boston, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management 11 to 50 2019
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity 1,001 to 5,000 2011
Tenstorrent Unicorn Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. Artificial intelligence Santa Clara, United States Series E $1.5B 2026-10-19 $2.5B Fidelity 501 to 1,000 2016
SiMa.ai SiMa.ai develops hardware and software for deploying physical AI applications at the edge. Artificial intelligence San Jose, United States Series C $150.0M 2026-09-28 $505.0M Fidelity 101 to 250 2018
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston, United States Series B $65.5M 2026-09-03 $223.5M RA Capital Management 11 to 50 2022
Claris Biotherapeutics Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. Biotech Jersey City, United States Series B $118.0M 2026-07-28 $225.1M RA Capital Management 1 to 10 2018
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London, United Kingdom Series A $33.6M 2026-07-09 $151.1M RA Capital Management, SV Health Investors 51 to 100 2019
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Cormorant Asset Management 11 to 50 2019
Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego, United States Series E $277.0M 2026-06-09 $678.0M Fidelity, RA Capital Management 251 to 500 2017
Coralogix Coralogix provides a SaaS platform that uses machine learning to support software delivery and maintenance. Artificial intelligence Boston, United States Series F $200.0M 2026-06-03 $550.8M Advent International 501 to 1,000 2014

Table 3. Post IPO investors in Boston, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 137 57%
Health care 99 41%
Biotech 82 34%
Hardware 45 19%
Artificial intelligence 40 17%
Fintech 25 10%
Commerce 23 10%
Education 11 5%
Cybersecurity 11 5%
Energy 5 2%

Table 4. Post IPO investors in Boston, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 5. Post IPO investors in Boston, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 1 3%
2010s 10 34%
2000s 6 21%
1990s 4 14%
1980s 6 21%
1960s 1 3%

Table 6. Post IPO investors in Boston, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many post ipo investors in Boston, Massachusetts are on the list?
33, in the file dated 16 November 2026. 10 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
20 of the 33 carry an email address in the download and 21 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 33 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 33 rows, 20 firm email addresses and 21 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 14 of the 20 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Post IPO investors in Boston, Massachusetts: 33 rows, CSV, $29 one-time.

At once: the CSV with 33 rows, 20 firm email addresses and 21 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 14 of the 20 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other stages in Boston

Post IPO investors elsewhere

Cite: FundingWatcher, 33 post ipo investors in Boston, Massachusetts, 16 November 2026. https://fundingwatcher.com/investors/stage/post-ipo-investors/boston-massachusetts/